WHO WE ARE

INEX Innovate is Asia's first
molecular diagnostics company for women

INEX Innovate is constantly innovating to address valuable clinical unmet needs with diagnostic test offerings, and has developed a broad range of IP.

EXPANSION

Strategic expansion into growing markets

DEVELOPMENT

Development of robust
product pipeline

INNOVATION

Commitment to excellence in laboratory practice

OUR FOCUS

Improving women’s health through

innovative diagnostics

Our commitment to
innovation

INEX is dedicated to applying our R&D and proven commercial capabilities to address unmet needs in women’s and fetal health.
We develop solutions to some of the most prevalent women’s health challenges whilst ensuring equity and access to products.
INNOVATION
PROGRESS
SYNERGY
IP
67
PARTNERSHIPS
25
TEAM
53
ONGOING PROJECTS
4
THE DIFFERENCE

We are a research-driven company with focus on developing diagnostics platforms based on hard science. We work to deliver value to the most important stakeholder — the patient.

MAKING STRIDES

Global Footprint

Singapore
USA
China
United Kingdom
Hong Kong
Indonesia
India
Bangladesh
Myanmar
Malaysia
Thailand
INSIGHTS

Latest news

Announcements

INEX Innovate receives European CE-IVD Certification for its OvaCis® Rapid Test

The team at INEX Innovate is proud to announce the attainment of CE marking for…
Announcements

INEX Innovate is the second-fastest growing healthcare company in Singapore

We’re incredibly proud to announce that INEX Innovatehas made its debut on the annual Financial…
Announcements

INEX named one of Straits Times ‘Fastest Growing Companies’

With an Annual Growth Rate of 294.6% and a Compound Annual Growth Rate (CAGR) of…
Announcements

Singapore’s SME Magazine sits with INEX Innovate’s Chief Executive Kane Black to discuss the challenges, inspiration, technology and what’s next for INEX Innovate and our wholly owned subsidiary iGene Laboratory